WorldGate Communications' Unattributed VC - VII Round

WorldGate Communications raised a round of funding on August 17, 2005.

Specializes in research, development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system. The company went public on February 1, 2005.…

Articles about WorldGate Communications' Unattributed VC - VII Round: